nonproprietary name


Also found in: Dictionary, Thesaurus, Legal, Financial, Encyclopedia.

non·pro·pri·e·tar·y name

(non'prō-prī'ĕ-tār'ē nām),
A short name (often called a generic name) of a chemical, drug, or other substance that is not subject to trademark (proprietary) rights but is, in contrast to a trivial name, recognized or recommended by government agencies (for example, U.S. Food and Drug Administration) and by quasiofficial organizations (for example, U.S. Adopted Names Council) for general public use. Like a proprietary name, it is almost always a coined designation derived without the use of set criteria. Compare: trivial name, proprietary name, semisystematic name, systematic name.

nonproprietary name

(nŏn′prə-prī′ĭ-tĕr′ē)
n.
The chemical or generic name of a drug, chemical, or device, as distinguished from a brand name or trademark.

nonproprietary name

[-prəprī′əter′ē]
Etymology: L, non + proprietas, owner, nomen, name
the chemical or generic name of a drug or device, as distinguished from a brand name or trademark. A nonproprietary name may be indicated by the letters USAN, for United States Adopted Names. See also USAN.

non·pro·pri·e·tar·y name

(non'prŏ-prī'ĕ-tar-ē nām)
A short name (often called a generic name) of a chemical, drug, or other substance that is not subject to trademark (proprietary) rights but is, in contrast to a trivial name, recognized or recommended by government agencies (e.g., The U.S. Food and Drug Administration) and by quasiofficial organizations (e.g., U.S. Adopted Names Council) for general public use.
Compare: trivial name, proprietary name, systematic name

non·pro·pri·e·tar·y name

(non'prŏ-prī'ĕ-tar-ē nām)
Short name (often called a generic name) of a chemical, drug, or other substance not subject to trademark (proprietary) rights but is, in contrast to a trivial name, recognized or recommended by government agencies (e.g., U.S. Food and Drug Administration) and by quasiofficial organizations (e.g., U.S. Adopted Names Council) for general public use. Like a proprietary name, it is almost always a coined designation derived without set criteria.
References in periodicals archive ?
Data from Australia, Japan, and Europe indicates that varying nonproprietary names reduces biosimilars' market presence, thus restricting competition in the market for biologies.
Baxter, a pharmacist in the UK, presents about 1900 monographs for drugs or drug groups organized in alphabetical order by International Nonproprietary Names, drawing from clinical studies, case reports, and systematic reviews and including ratings on the clinical significance of the interaction in terms of action, severity, and evidence.
The Biosimilars Council, a division of GPhA, is concerned that different international nonproprietary names for biologics and biosimilars could lead to patient and provider confusion, increasing the likelihood of prescribing errors and other unintended consequences.
This report explains new standards and guidelines the committee recently adopted and recommended for use, specifically the International Chemical Reference Substances and International Infrared Reference Spectra, specifications (in principle) for male latex condoms and Tcu380A intrauterine devices for purchase by United Nations agencies, active pharmaceutical ingredient master file procedures and international nonproprietary names for biological and biotechnological substances.
The entries, which are organized alphabetically, each contain a list of nonproprietary names and synonyms; detailed chemical information, including the structural formula; a description; applications; method of manufacture; handling precautions; regulatory status; and related substances, among other information.
We strongly believe the final regulatory structure for biosimilars must include mechanisms to allow for robust post-marketing data collection and evaluation along with unique trade and nonproprietary names, so that safety issues can be recognized quickly and patient risk can be limited.
The Company also announced today that the United States Adopted Names Council (USAN) and World Health Organization (WHO) International Nonproprietary Names (INN) Expert Committee have approved palifosfamide as the non-proprietary name for isofosforamide mustard (IPM), the active pharmaceutical ingredient in ZIO-201.
Food and Drug Administration (FDA) asking the agency to require biosimilars to bear nonproprietary names that are similar to, but not the same as, those of their reference products or of other biosimilars.
Separately the Company announced that the United States Adopted Names Council (USAN) and World Health Organization (WHO) International Nonproprietary Names (INN) Expert Committee have approved darinaparsin as the non-proprietary name for ZIO-101 (for all forms of the drug).
Food, Drug, and Cosmetic Act, USP plays a role in the adulteration and misbranding provisions, including specifying nonproprietary names of drug substances and drug products when compendial monographs are published and made official.
In July 2006 the International Nonproprietary Names (INN) body of the World Health Organization (WHO) and the United States Adopted Names (USAN) Council approved the nonproprietary (generic) name romidepsin for depsipeptide (FK228).
Moving forward, we will work to ensure that no barriers, like unique nonproprietary names or unnecessary clinical trials, are put in place that could raise safety concerns or interfere with the competitive market BPCIA was designed to create.